
Exemplary growth in Turkey
3 September 2008
In partnership with Diagno Grup, a distributor located in Istanbul, Ankara and Izmir, HORIBA ABX recorded sales growth in Turkey of 35% last year, with 50% of sales made up by reagents. The Turkish market has become the most dynamic European market due to a political drive to catch up with healthcare standards in other European countries.
In Turkey, HORIBA ABX mainly sells systems from the PENTRA 120 family for hospitals. Stéphane Rougale, Distributor Network Manager and Artin Sandalci, Director of Diagno Grup, consider that "a 20% market share has been achieved through double digit growth over the past four years, which has been sustained thanks to innovative financing solutions developed within the framework of a French-Turkish partnership".
Archive
- April 2012 (2)
- November 2011 (1)
- October 2011 (1)
- September 2011 (1)
- August 2011 (3)
- June 2011 (1)
- May 2011 (1)
- March 2011 (2)
- February 2011 (1)
- December 2010 (2)
- November 2010 (1)
- October 2010 (4)
- September 2010 (2)
- August 2010 (1)
- July 2010 (1)
- April 2010 (1)
- March 2010 (5)
- January 2010 (2)
- October 2009 (2)
- September 2009 (1)
- August 2009 (2)
- June 2009 (2)
- May 2009 (3)
- February 2009 (1)
- January 2009 (1)
- December 2008 (1)
- October 2008 (1)
- September 2008 (9)
- August 2008 (1)
- June 2008 (1)
- May 2008 (1)
- January 2008 (1)
News feed
Subscribe to our news feed:

